MedAlliance Sirolimus Drug Eluting Balloon Gains Second ... | 合法醫療器材資訊網

由 G Caiazzo 著作 · 2020 · 被引用 1 次 — Sirolimus-coated balloons (SCBs) represent a novel therapeutic option for both in​-stent restenosis (ISR) and de novo coronary lesions ... Read More

2020年6月17日 — MedAlliance Sirolimus Drug Eluting Balloon Gains Second European CE Mark. MedAlliance announced its second CE mark approval for its ... Read More

The surface of these balloons carry antiproliferative drugs such as paclitaxel or sirolimus that is delivered to the vessel wall when inflated. The drug helps prevent ... Read More

The balloons carry an antiproliferative drug that is delivered to the wall of arteries when the balloon is expanded. The drug helps prevent neointimal hyperplasia ( ... Read More

Novel treatments for in-stent restenosis: sirolimus-eluting balloons enter the arena. ... Contemporary new-generation drug-eluting stents (DES), with improved​ ... Read More

由 G Caiazzo 著作 · 被引用 1 次 — Sirolimus-coated balloons (SCBs) represent a novel therapeutic option for both ... Drug-eluting stents (DES) are the gold standard devices for percutaneous ... Read More

In the study published by Takimura et al.5 in this issue of Revista Brasileira de Cardiologia Invasiva, the authors tested a new drug-eluting balloon using sirolimus ... Read More

The DEVOIR Sirolimus coated balloon is indicated to dilate the diseased segment(s) and deliver drug in a coronary artery to improve myocardial perfusion with ... Read More

About SELUTION SLR™. MedAlliance is the first and only company able to deliver the antiproliferative drug sirolimus in a drug-eluting balloon ... Read More

由 YP Clever 著作 · 2016 · 被引用 42 次 — Conclusions—Various sirolimus-coated balloons effectively reduce neointimal proliferation ... drug-coated balloon ◼ drug-eluting stent ◼ neointima ◼ sirolimus. Read More